[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351776-105":59,"doc-detail-351776-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-targetable-developmental-program-coregulates-angiogenesis-and-immune-evasion-in-melanoma","A Targetable Developmental Program Coregulates Angiogenesis and Immune Evasion in Melanoma","","Ultraviolet-induced DNA mutations create melanoma genetic drivers and neoantigens that can trigger antitumor immunity, forcing cancer cells to rapidly evade immune detection. This study identifies the homeodomain transcription factor HOXD13 as a melanoblast-like program elevated in melanoma and linked to angiogenesis and immune cell exclusion. Using transcriptomics, 3D chromatin profiling, and in vivo models, HOXD13 promotes tumor growth by enhancing angiogenesis and suppressing T-cell infiltration through enhancer–promoter activation of VEGFA, SEMA3A, and NT5E/CD73, raising immunosuppressive adenosine. Dual VEGFR and adenosine receptor inhibition counteracts HOXD13-driven growth.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-targetable-developmental-program-coregulates-angiogenesis-and-immune-evasion-in-melanoma/351776/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-targetable-developmental-program-coregulates-angiogenesis-and-immune-evasion-in-melanoma/351776.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study identify as a key transcription factor in melanoma immune evasion?","Question",{"text":112,"@type":113},"The transcription factor HOXD13 drives a melanoblast-like program upregulated in melanoma and correlates with angiogenesis and immune cell exclusion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does HOXD13 influence both angiogenesis and immune infiltration?",{"text":117,"@type":113},"HOXD13 promotes tumor growth by enhancing angiogenesis while suppressing T-cell infiltration, remodeling the tumor vasculature and limiting immune entry.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic strategy counters the HOXD13-driven tumor effects?",{"text":121,"@type":113},"Combined inhibition of VEGFR signaling and adenosine receptors reverses HOXD13-induced tumor growth by targeting both proangiogenic and immunosuppressive pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351776,1790499868,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","ReseaRch aRticle  \nA Targetable Developmental Program CoregulatesAngiogenesis and Immune Evasion in Melanoma   \nPietro Berico1,2, Amanda Flores Yanke1,2, Fatemeh Vand-Rajabpour1,2, Catherine Do1,3, Irving Simonin Wilmer4, Ines Delclaux2,5, Tara Muijlwijk2,5, Robert Stagnitta2,5,  \nMartha Estefania Vázquez-Cruz4, Theodore Sakellaropoulos1,3, Matheus Ribeiro Costa6, Annie Cristhine Moraes Sousa-Squiavinato6, Michelle Krogsgaard1,2,3, Ata S. Moshiri5, Iman Osman2,5, Jane A. Skok1,3, Patricia A. Possik6, Carla Daniela Robles-Espinoza4, Amanda W. Lund2,5, Markus Schober2,5, and Eva Hernando1,2  \nUltraviolet-induced DNA mutations generate genetic drivers of cutaneous mela  \nnoma and numerous neoantigens that can trigger antitumor immunity. Melanoma cells must therefore rapidly evade immune detection by modulating cell-autonomous epigenetic mechanisms and tumor–microenvironment interactions. Although angiogenesis typically facilitates immune infiltration, solid tumors increase vascularization while limiting immune cell entry. By comparing transcription factor (TF) expression across early-stage melanoma, nevi, and other cancers, we found that the homeodomain TF HOXD13 drives a melanoblast-like program upregulated in melanoma and strongly correlated with angiogenesis and immune cell exclusion. Using transcriptomics, 3D chromatin profiling, and in vivo models, we show that HOXD13 promotes tumor growth by enhancing angiogenesis and suppressing T-cell infiltration. HOXD13 orchestrates 3D enhancer–promoter contacts activating VEGFA, SEMA3A, and NT5E (CD73), which remodel vasculature and elevate immunosuppressive adenosine. Consistently, HOXD13-induced tumor growth is reversed by combined VEGFR and adenosine receptor (AdR) inhibition, revealing a dual proangiogenic and immunosuppressive HOXD13 axis with therapeutic relevance.  \nSIgnIfICAnCE: Immune evasion contributes to cancer progression and poor response to immunotherapy. We report a novel epigenetic mechanism led by the TF HOXD13, allowing melanoma cells to simultaneously inhibit and exclude T cells, which can be counteracted therapeutically using VEGF and AdR inhibitors.  \nintRoduction  \nEfficient physiologic immune responses require an increase in tissue vasculature. Paradoxically, many solid tumors find ways to simultaneously activate angiogenesis to support their increasing demands for oxygen and nutrients (1) while excluding immune cells (2) . The tumor vasculature’s morphology, maturation, and activity have recently emerged as significant determinants of immune cell homing, activity, and immunotherapy response (3–5) . However, the molecular mechanisms by which cancer cells govern an immune-refractory angiogenic process are largely unknown. In this context, skin cutaneous melanoma (SKCM) represents an exquisite study model. Because ultraviolet (UV)-driven mutations generate highly immunogenic neoantigens (6–9), melanoma cells are subject to strong immune surveillance and must also adapt  \n1Department of Pathology, NYU Grossman School of Medicine, New York, New York. 2 Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, NYU Langone Health, New York, New York. 3Perlmutter  \nCancer Center, NYU Langone Health, New York, New York. 4 International Laboratory for Human Genome Research (LIIGH), National Autonomous University of Mexico (UNAM), Juriquilla, Mexico. 5Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York. 6Division of Basic and Experimental Research, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.  \nCorresponding Authors: Eva Hernando, Department of Pathology, NYULangone Medical Center, 550 1st Av., NYU Langone Health Smilow 305, New York, NY 10016. E-mail: [Eva.Hernando-Monge@nyulangone.org](Eva.Hernando-Monge@nyulangone.org); and Pietro Berico, [Pietro.Berico@nyulangone.org](Pietro.Berico@nyulangone.org)  \nCancer Discov 2026;16:1200–21  \ndoi: 10. 1158/2159-8290 . CD-24-1853  \nThis open access article","cbCaibZsJIvMELgH","https://ap.wps.com/l/cbCaibZsJIvMELgH","pdf",11803648,22,"English","# Introduction\n## Immune surveillance and tumor immune escape\n## Angiogenesis–immunity relationship in solid tumors\n# Results\n## HOXD13 links angiogenesis with immune exclusion\n## HOXD13 mechanism via 3D enhancer–promoter contacts","[{\"question\":\"What does the study identify as a key transcription factor in melanoma immune evasion?\",\"answer\":\"The transcription factor HOXD13 drives a melanoblast-like program upregulated in melanoma and correlates with angiogenesis and immune cell exclusion.\"},{\"question\":\"How does HOXD13 influence both angiogenesis and immune infiltration?\",\"answer\":\"HOXD13 promotes tumor growth by enhancing angiogenesis while suppressing T-cell infiltration, remodeling the tumor vasculature and limiting immune entry.\"},{\"question\":\"What therapeutic strategy counters the HOXD13-driven tumor effects?\",\"answer\":\"Combined inhibition of VEGFR signaling and adenosine receptors reverses HOXD13-induced tumor growth by targeting both proangiogenic and immunosuppressive pathways.\"}]","A Targetable Developmental Program Coregulates Angiogenesis and Immune Evasion in Melanoma | PDF",1790095854,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc04c6e12178c5b23b191d62a7efe5e7.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc65a2ed95ed91c8b868646327316cce.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e9e65b22d44a70ce7dc29a176d2ed4b.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f9e633c618e77d9f30dddae120726c4.webp",980,1311]